Unity Biotechnology, Inc. (LON:0YC0)
London · Delayed Price · Currency is GBP · Price in USD 0.0800
-0.0010 (-1.23%)
At close: Aug 14, 2025
Unity Biotechnology Market Cap
Unity Biotechnology has a market cap or net worth of 1.15 million as of August 15, 2025. Its market cap has decreased by -94.25% in one year.
Market Cap
1.15M
Enterprise Value
5.33M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since May 3, 2018, Unity Biotechnology's market cap has decreased from 514.98M to 1.15M, a decrease of -99.78%. That is a compound annual growth rate of -56.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 1.15M | -91.24% |
| Dec 31, 2024 | 13.14M | -48.33% |
| Dec 29, 2023 | 25.43M | -21.20% |
| Dec 30, 2022 | 32.27M | -48.15% |
| Dec 31, 2021 | 62.24M | -69.35% |
| Dec 31, 2020 | 203.08M | -18.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 3, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 179.76B |
| GSK plc | 57.11B |
| Haleon | 31.97B |
| Smith & Nephew | 11.74B |
| ConvaTec Group | 4.66B |
| Hikma Pharmaceuticals | 3.97B |
| HUTCHMED (China) | 2.09B |
| Oxford Nanopore Technologies | 2.02B |